In an interesting turn of events, public outcry has erupted following the appointment of Dr. Charles Githinji as the Chairperson of the Pharmacy and Poisons Board.
Recent revelations by the Consumers Federation of Kenya (COFEK) have exposed Dr. Githinji’s conviction for gross negligence and professional misconduct, prompting urgent demands for his immediate removal from the position.
The controversy stems from a case documented in the Kenya Gazette No. 630 of January 20, 2023, which announced Dr. Githinji’s appointment.
However, it was the subsequent judgment on HCCC No. 34 of 2012 that shed light on the Chairperson’s questionable past.
On May 29, 2019, Justice A. Mbogholi Msagha delivered a verdict that revealed Dr. Githinji’s conviction and cast serious doubt on his fitness for the role.
The case centered on a complaint filed by LWW, representing the estate of BMN, against Dr. Charles Githinji.
Both the Kenya Medical Practitioners and Dentists Council (KMPDC) and the High Court found him guilty of grave professional misconduct and exceeding the bounds of his pharmacist responsibilities.
The KMPDC, after a thorough investigation, issued a decision holding pharmacist Charles Githua Githinji accountable.
The KMPDC’s findings stated that the complaint against Dr. Githinji had merit.
It was determined that his actions, including a failure to take a proper medical history, led to improper diagnosis and the inappropriate prescription of medication, resulting in the untimely death of BMN.
It was revealed that Dr. Githinji had misrepresented himself as a medical practitioner and engaged in diagnostic and curative services, misleading the committee overseeing the case.
As a result, the pharmacist was ordered to pay costs amounting to Kshs. 27,000/-.
Adding to the severity of the situation, the High Court awarded the plaintiff Sh1.05 million as general damages, underscoring the devastating consequences of Dr. Githinji’s actions.
Critics argue that Dr. Githinji’s conviction raises serious concerns about the regulatory standards and legitimacy of the Pharmacy and Poisons Board.
They assert an individual convicted of such a significant offense, resulting in the loss of a life, should not be entrusted with leading a vital public regulatory body.
Stephen Mutoro, the Secretary General of COFEK, has expressed grave concern over Dr. Githinji’s appointment.
“It is clear that Dr. Githinji acted unprofessionally and without remorse, except for his own self-gain. The regulatory threshold and legitimacy of the Pharmacy and Poisons Board can no longer stand on this basis. The interests of millions of Kenyan consumers are at stake,” stated Mutoro.
In response to the mounting public pressure, COFEK has issued a list of demands.
Mr. Mutoro is calling for the immediate revocation of Dr. Charles Githinji’s appointment as Chairperson, preferably within 14 days of their demand.
He further insists that all decisions made by the Pharmacy and Poisons Board during Dr. Githinji’s tenure be declared null and void.
COFEK seeks to hold Dr. Githinji financially responsible for any expenses incurred by the Board as a result of his misrepresentation.
Failure to address these demands within the stipulated timeframe could result in legal action against the Ministry of Health and the Pharmacy and Poisons Board.
As public outrage intensifies, the fate of Dr. Charles Githinji hangs in the balance, while the Ministry of Health faces mounting pressure to rectify the situation and restore public trust in the regulatory processes.
The Ministry of Health and the Pharmacy and Poisons Board have yet to respond to the demands, leaving concerned parties eagerly awaiting an official statement.
When Truth is not Free, Freedom is not True.